ROWLAND LLOYD A

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
8 12% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -85%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
ROWLAND LLOYD A's trades of CytomX Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
10.33
Quantity 9,000 +919.3%
Value US$92,970
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-20 2025-03-18
S Sale
62,125 -25.7%
201.64
US$2,896,252 		62,125 -25.7% 201.64 US$2,896,252
2024-08-22 2024-08-20
S Sale
22,591 -14.2%
411.27
US$2,391,655 		22,591 -14.2% 411.27 US$2,391,655
2024-03-21 2024-03-19
S Sale
19,732 -16.1%
192.43
US$3,299,434 		19,732 -16.1% 192.43 US$3,299,434
2023-12-22 2023-12-20
S Sale
4,077 -4.0%
1.38
US$5,629 		4,077 -4.0% 1.38 US$5,629
2023-09-22 2023-09-22
S Sale
5,486 -6.4%
1.30
US$7,135 		5,486 -6.4% 1.30 US$7,135
2023-03-20 2023-03-16
S Sale
2,037 -2.8%
1.98
US$4,031 		2,037 -2.8% 1.98 US$4,031
2022-07-21 2022-07-20
S Sale
5,602 -11.4%
1.42
US$7,968 		5,602 -11.4% 1.42 US$7,968
2019-03-05 2019-03-04
B Purchase
9,000 +919.3%
10.33
US$92,970 		9,000 +919.3% 10.33 US$92,970